Ann Arbor pharm company brings drug closer to market
A drug some are calling the female Viagara is one step closer to market. Ophena, developed by Ann Arbor drug company QuatRX Pharmaceuticals Co., was designed to treat a post-menopausal condition that makes sexual activity difficult or painful. QuatRX recently reported good results from a late-stage study.
A drug some are calling the female Viagara is one step closer to market. Ophena, developed by Ann Arbor drug company QuatRX Pharmaceuticals Co., was designed to treat a post-menopausal condition that makes sexual activity difficult or painful. QuatRX recently reported good results from a late-stage study.
Excerpt: The company expects to meet soon with the Food and Drug Administration to discuss its second Phase 3 study – which would have to confirm the positive results of its first Phase 3 study. Some 826 women participated in the study at 80 medical centers throughout the country. QuatRx hopes to complete the final study and file a new drug application with the FDA by late 2009 or early 2010. Its first Phase 3 study took about 19 months.
Read the entire article here.
THIS STORY FIRST APPEARED IN METROMODE
Related Articles
Ypsi’s We the People Opportunity Farm will continue founder Melvin Parson’s mission after his sudden passing
Leadership at Ypsilanti nonprofit We The People Opportunity Farm is focused on ensuring the organization continues founder Melvin Parson’s legacy after his unexpected death.
Making sports and fitness accessible to Ypsi-area kids is this nonprofit’s focus
The grassroots nonprofit Ypsilanti Community – The Village was created by Ypsilanti Community High School alumni who wanted to reduce young people’s barriers to participating in sports.
Ypsi schools’ Mental Health Awareness Fair aims to offer resources, reduce stigma
Ypsilanti Community Schools are celebrating Mental Health Awareness Month with their fourth annual Mental Health Awareness Fair on May 16 from noon-3 p.m. at Prospect Park in Ypsilanti.
